WASHINGTON, March 19, 2018 /PRNewswire/ -- The Investment Program Association (IPA) today announced the launch of IPA Chapters, a national initiative designed to deliver timely education and ...
ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) has developed a new class of GLP-1 therapies entirely through artificial intelligence, designed to enhance efficacy, safety, therapy longevity, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results